Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Bilal Abid

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2020
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor TransplantationMuhammad Bilal Abid, Mehdi Hamadani, Aniko Szabo, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2017
The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferationsSanjay de Mel, Jenny Bei Li, Muhammad Bilal Abid, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2018
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent InductionMuhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, et al.
Bone Marrow Transplantation|December 21, 2022
The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR studyMuthalagu Ramanathan, Soyoung Kim, Naya He, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Transplantation and Cellular Therapy|October 14, 2020
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT OutcomesChristine Camacho-Bydume, Tao Wang, Jennifer A Sees, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
British Journal of Haematology|March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant responseOren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Transplantation and Cellular Therapy|September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid MalignancyNina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2020
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor TransplantationMuhammad Bilal Abid, Mehdi Hamadani, Aniko Szabo, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2017
The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferationsSanjay de Mel, Jenny Bei Li, Muhammad Bilal Abid, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2018
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent InductionMuhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, et al.
Bone Marrow Transplantation|December 21, 2022
The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR studyMuthalagu Ramanathan, Soyoung Kim, Naya He, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Transplantation and Cellular Therapy|October 14, 2020
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT OutcomesChristine Camacho-Bydume, Tao Wang, Jennifer A Sees, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
British Journal of Haematology|March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant responseOren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Transplantation and Cellular Therapy|September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid MalignancyNina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Pageof 7